Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Evotec and Ferring Form Strategic Research Small Molecule Discovery and Development Medicine and Women's Health

publication date: Nov 2, 2018
 | 
author/source: Evotec AG

evotecFerring Accesses Evotec's Integrated Small Molecule Discovery and Development Platform to Progress New Molecules from Concept to Potential Drug Candidates.

Evotec is Eligible for Undiscovered Research Funding and Milestones

Evotec AG and Ferring Pharmaceuticals ("Ferring") has announced a strategic research alliance to discover and develop new small molecule therapies to treat patients living with fertility and gynaecological conditions.

Evotec will apply its drug discovery platform to design novel, safe and efficacious treatments in partnership with Ferring. The multi-target, multi-year collaboration aims to deliver small molecule pre-clinical development ("PDC") and investigational new drug ("IND") ready candidates. As part of the alliance, Evotec is eligible for undisclosed research funding and milestones.

Dr Mario Polywka, Chief Operating Officer of Evotec, commented: "The integration of our industry-leading small molecule discovery and development platform with Ferring's deep disease expertise in reproductive medicine and women's health will create a powerful combination that we hope will create a difference for patients suffering from infertility and gynaecological disorders. We very much look forward to working with such an innovative partner."

Per Falk, Chief Science Officer, Ferring, added: "To achieve leadership in reproductive medicine and women's health, we are expanding beyond our historical expertise in peptides and tackling molecular targets that are best addressed using small molecule therapeutics. Evotec is a highly regarded company in this field, and this alliance offers the prospect of significant innovation for patients. Together, we have the potential to make a difference for both men and women who are struggling to start a family, and for women suffering from gynaecological conditions."




 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events